Cleveland Diagnostics (formerly AnalizaDx) is developing applications of its proprietary platform for the in vitro cancer diagnostic market. The technology is a fundamentally different method for biomarker identification and quantification that addresses the clinical problems posed by natural biological variation in protein levels.
Funding
JumpStart, Strategic Partner